Alzamend Neuroâ˘, Inc. (âAlzamendâ˘â) is a biotechnology company dedicated to the research, development and commercialization of pharmaceuticals for the treatment and cure of Alzheimerâs disease. Alzamend Neuro⢠is currently working to transition two therapeutics targeting Alzheimerâs disease (âADâ) from the research and preclinical stage at the University of South Florida into the clinical stage and towards full commercialization. Alzamend Neuro⢠has licensed both a patented mutant-peptide immunotherapeutic (CAO22W) for use as a treatment or vaccine and a lithium based ionic cocrystal therapy (LiProSalâ˘) that may greatly reduce or eliminate the symptoms of agitation and other endpoints for mild to moderate stage patients diagnosed with AD. There are no profound treatments today for Alzheimerâs disease. With CAO22W and LiProSalâ˘, the Company believes that Alzamend⢠can change that.
No articles found.
Personalis, Inc. is a growing cancer genomics company transforming the development...
Personalis, Inc. is a growing cancer genomics c...
Accuray develops, manufactures and sells radiation oncology systems that make canc...
Accuray develops, manufactures and sells radiat...
STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, de...
STAAR, which has been dedicated solely to ophth...
We are a late stage biopharmaceutical company focused on the development and comme...
We are a late stage biopharmaceutical company f...
Cortexyme is a biopharmaceutical company developing therapeutics based on data sup...
Cortexyme is a biopharmaceutical company develo...
We are a gene therapy company dedicated to developing and commercializing novel tr...
We are a gene therapy company dedicated to deve...
Dollar Shots Club sells subscription supplement shots for early mornings, late nig...
Dollar Shots Club sells subscription supplement...
Our current primary focus verticals are the US human and pet wellness CBD market a...
Our current primary focus verticals are the US ...
Our current primary focus verticals are the US human and pet wellness CBD market a...
Our current primary focus verticals are the US ...
Cortexyme is a biopharmaceutical company developing therapeutics based on data sup...
Cortexyme is a biopharmaceutical company develo...
Join the National Investor Network and get the latest information with your interests in mind.